Search filters

List of works by Mitchell Ho

A Human Single-Domain Antibody Elicits Potent Antitumor Activity by Targeting an Epitope in Mesothelin Close to the Cancer Cell Surface

scientific article published on January 31, 2013

A frizzled‐like cysteine rich domain in glypican‐3 mediates Wnt binding and regulates hepatocellular carcinoma tumor growth in mice

scientific article published on 24 May 2019

A proteomic atlas of glypican‐3 interacting partners: Identification of alpha‐fetoprotein and other extracellular proteins as potential immunotherapy targets in liver cancer

scientific article published in 2024

CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice

scientific article published on 01 June 2021

COVID-19 antibody therapeutics tracker: a global online database of antibody therapeutics for the prevention and treatment of COVID-19

scientific article published on 01 July 2020

Changes in Global Gene Expression Associated with 3D Structure of Tumors: An Ex Vivo Matrix-Free Mesothelioma Spheroid Model

scientific article published on June 21, 2012

Cloning and sequence analysis of cDNAs encoding the heavy and light chain variable regions of an Ab2β anti-idiotypic monoclonal antibody possessing an internal image of cocaine

scientific article published on October 31, 2001

DNA damaging agent-based antibody-drug conjugates for cancer therapy

scientific article published on 30 August 2018

Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update

scientific article published on 20 June 2020

Efficacy of anti‐insulin‐like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor‐I receptor sites/cell

scientific article published on April 24, 2012

Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum Retention

scientific article published on 14 September 2019

Glypican-3: A new target for cancer immunotherapy

scientific article published on November 26, 2010

HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer Therapy

scientific article published on May 16, 2011

High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array

scientific article published on October 21, 2010

In Vivo Imaging of Human Malignant Mesothelioma Grown Orthotopically in the Peritoneal Cavity of Nude Mice

scientific article published on March 1, 2011

Mesothelin as a Potential Therapeutic Target in Human Cholangiocarcinoma

scientific article published on October 1, 2010

R-spondins engage heparan sulfate proteoglycans to potentiate WNT signaling

scientific article published on 20 May 2020

Rapid Generation of In Vitro Multicellular Spheroids for the Study of Monoclonal Antibody Therapy

scientific article published on October 13, 2011

Recombinant immunotoxins with albumin-binding domains have long half-lives and high antitumor activity.

scientific article published on 26 March 2018

Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update

scientific article published on November 12, 2012

The Development and Characterization of a Human Mesothelioma In Vitro 3D Model to Investigate Immunotoxin Therapy

scientific article published on January 31, 2011

The Role of Mesothelin in Tumor Progression and Targeted Therapy

scientific article published on February 1, 2013

Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma.

scientific article published on 24 July 2017

Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma

scientific article published on March 5, 2013